Alzheimer's Disease

Ongoing studies are examining Mesenchymal Stem Cells (MSCs) in Alzheimer’s disease, with attention to clinical feasibility, safety considerations, and their possible impact on neuroinflammatory processes and neuronal health. 

Alzheimer’s disease is the most common cause of dementia and is characterized by progressive memory loss, cognitive decline, and changes in behavior. It involves abnormal accumulation of proteins in the brain, leading to the loss of neurons and synapses. Existing treatments can provide temporary symptom relief and to some extent slow down but not stop disease progression. 

MSC studies in Alzheimer’s disease are still in early stages. Researchers are investigating whether their immunomodulatory and neuroprotective properties could contribute to maintaining brain function. While results remain preliminary, this work is expanding the scientific foundation for potential new approaches in dementia research.